Report Detail
Global Viral Vectors and Plasmid DNA Manufacturing Market Size, Status and Forecast 2019-2025
- RnM3126688 |
- 20 March, 2019 |
- Global |
- 105 Pages |
- QYResearch |
- Other
The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.
Based on classification, the proportion of Viral Vectors Manufacturing in 2016 is about 79.74%, with revenue about 200 M USD. Based on application, Cancers segment accounted for larger market share in terms of sales in 2016, vascular segmented accounted for more than 61% of the market share in 2016.
North America is the largest consumption place, with a consumption market share nearly 51% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 34% in 2016.
Market competition is intense among top 5. BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
In 2018, the global Viral Vectors and Plasmid DNA Manufacturing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Viral Vectors and Plasmid DNA Manufacturing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Viral Vectors and Plasmid DNA Manufacturing development in United States, Europe and China.
The key players covered in this study
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
VGXI
PlasmidFactory
Market segment by Type, the product can be split into
Plasmid DNA
Viral Vectors
Market segment by Application, split into
Cancers
Inherited Disorders
Viral Infections
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Viral Vectors and Plasmid DNA Manufacturing status, future forecast, growth opportunity, key market and key players.
To present the Viral Vectors and Plasmid DNA Manufacturing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Viral Vectors and Plasmid DNA Manufacturing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Plasmid DNA
- 1.4.3 Viral Vectors
- 1.5 Market by Application
- 1.5.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2014-2025)
- 1.5.2 Cancers
- 1.5.3 Inherited Disorders
- 1.5.4 Viral Infections
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Viral Vectors and Plasmid DNA Manufacturing Market Size
- 2.2 Viral Vectors and Plasmid DNA Manufacturing Growth Trends by Regions
- 2.2.1 Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions (2014-2025)
- 2.2.2 Viral Vectors and Plasmid DNA Manufacturing Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Viral Vectors and Plasmid DNA Manufacturing Market Size by Manufacturers
- 3.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
- 3.2 Viral Vectors and Plasmid DNA Manufacturing Key Players Head office and Area Served
- 3.3 Key Players Viral Vectors and Plasmid DNA Manufacturing Product/Solution/Service
- 3.4 Date of Enter into Viral Vectors and Plasmid DNA Manufacturing Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2014-2019)
- 4.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2014-2019)
5 United States
- 5.1 United States Viral Vectors and Plasmid DNA Manufacturing Market Size (2014-2019)
- 5.2 Viral Vectors and Plasmid DNA Manufacturing Key Players in United States
- 5.3 United States Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 5.4 United States Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
6 Europe
- 6.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size (2014-2019)
- 6.2 Viral Vectors and Plasmid DNA Manufacturing Key Players in Europe
- 6.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 6.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
7 China
- 7.1 China Viral Vectors and Plasmid DNA Manufacturing Market Size (2014-2019)
- 7.2 Viral Vectors and Plasmid DNA Manufacturing Key Players in China
- 7.3 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 7.4 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
8 Japan
- 8.1 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size (2014-2019)
- 8.2 Viral Vectors and Plasmid DNA Manufacturing Key Players in Japan
- 8.3 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 8.4 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size (2014-2019)
- 9.2 Viral Vectors and Plasmid DNA Manufacturing Key Players in Southeast Asia
- 9.3 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 9.4 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
10 India
- 10.1 India Viral Vectors and Plasmid DNA Manufacturing Market Size (2014-2019)
- 10.2 Viral Vectors and Plasmid DNA Manufacturing Key Players in India
- 10.3 India Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 10.4 India Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
11 Central & South America
- 11.1 Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size (2014-2019)
- 11.2 Viral Vectors and Plasmid DNA Manufacturing Key Players in Central & South America
- 11.3 Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 11.4 Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
12 International Players Profiles
- 12.1 BioReliance
- 12.1.1 BioReliance Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Viral Vectors and Plasmid DNA Manufacturing Introduction
- 12.1.4 BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2014-2019)
- 12.1.5 BioReliance Recent Development
- 12.2 Cobra Biologics
- 12.2.1 Cobra Biologics Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Viral Vectors and Plasmid DNA Manufacturing Introduction
- 12.2.4 Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2014-2019)
- 12.2.5 Cobra Biologics Recent Development
- 12.3 Oxford BioMedica
- 12.3.1 Oxford BioMedica Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Viral Vectors and Plasmid DNA Manufacturing Introduction
- 12.3.4 Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2014-2019)
- 12.3.5 Oxford BioMedica Recent Development
- 12.4 UniQure
- 12.4.1 UniQure Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Viral Vectors and Plasmid DNA Manufacturing Introduction
- 12.4.4 UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2014-2019)
- 12.4.5 UniQure Recent Development
- 12.5 FinVector
- 12.5.1 FinVector Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Viral Vectors and Plasmid DNA Manufacturing Introduction
- 12.5.4 FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2014-2019)
- 12.5.5 FinVector Recent Development
- 12.6 MolMed
- 12.6.1 MolMed Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Viral Vectors and Plasmid DNA Manufacturing Introduction
- 12.6.4 MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2014-2019)
- 12.6.5 MolMed Recent Development
- 12.7 MassBiologics
- 12.7.1 MassBiologics Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Viral Vectors and Plasmid DNA Manufacturing Introduction
- 12.7.4 MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2014-2019)
- 12.7.5 MassBiologics Recent Development
- 12.8 Richter-Helm
- 12.8.1 Richter-Helm Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Viral Vectors and Plasmid DNA Manufacturing Introduction
- 12.8.4 Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2014-2019)
- 12.8.5 Richter-Helm Recent Development
- 12.9 FUJIFILM Diosynth Biotechnologies
- 12.9.1 FUJIFILM Diosynth Biotechnologies Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Viral Vectors and Plasmid DNA Manufacturing Introduction
- 12.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2014-2019)
- 12.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
- 12.10 Lonza
- 12.10.1 Lonza Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Viral Vectors and Plasmid DNA Manufacturing Introduction
- 12.10.4 Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2014-2019)
- 12.10.5 Lonza Recent Development
- 12.11 Aldevron
- 12.12 Eurogentec
- 12.13 Cell and Gene Therapy Catapult
- 12.14 Biovian
- 12.15 Brammer Bio
- 12.16 VGXI
- 12.17 PlasmidFactory
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Viral Vectors and Plasmid DNA Manufacturing . Industry analysis & Market Report on Viral Vectors and Plasmid DNA Manufacturing is a syndicated market report, published as Global Viral Vectors and Plasmid DNA Manufacturing Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Viral Vectors and Plasmid DNA Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
